This protocol describes a survey undertaken to acquire a snapshot of the distribution of Clostridioides difficile strains in tertiary acute care hospitals in the European Union/European Economic Area (EU/EEA) in 2022–2023
This reporting protocol is for the 2024 data call for antimicrobial resistance (AMR) surveillance data, collected by the European Antimicrobial Resistance Surveillance Network (EARS-Net) for 2023.
Joint statement by the European Centre for Disease Prevention and Control, European Chemicals Agency, European Environment Agency, European Food Safety Authority and European Medicines Agency.
The Protocol is targeted at the national public health reference laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.
ECDC publishes a protocol developed for the surveillance of Clostridioides (Clostridium) difficile infections (CDI) to address the lack of standardised surveillance of CDI in EU Member States.
This updated protocol prescribes the methodology, and provides the data collection tools required to achieve the objectives of European surveillance of CDIs.
This document establishes a protocol for the case detection, laboratory diagnosis and environmental testing of Mycobacterium chimaera infections which are potentially associated with heater-cooler units.
This protocol for harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter from human isolates aims to increase the quality and comparability of antimicrobial resistance data collected at the EU level from different Member States. It is primarily targeted to the National Public Health Reference Laboratories to guide the susceptibility testing needed for EU surveillance and the reporting to ECDC.
The toolkit contains template materials and some suggested key messages focusing on self-medication with antibiotics, ideas for awareness raising activities, and suggested tactics for getting the messages across to the general public regarding prudent use of antibiotics, especially to people self-medicating with antibiotics.
This guidance document is based on research of social media activity related to antibiotic use at EU level, as well as on a survey of the social media activities of EAAD partner organisations, mostly EU umbrella organisations of patients and health professionals. Following the research and the survey, we have proposed social media activities that could be undertaken as part of national prudent antibiotic use campaigns. The proposed activities are presented in three sections that are targeting the general public, primary care prescribers and hospital prescribers.